Skip to main content
Log in

A Systematic Review of Platelet-Rich Plasma in the Management of Upper Limb Tendinopathies

  • Published:
Regenerative Engineering and Translational Medicine Aims and scope Submit manuscript



Currently, gold standards for treating upper-limb tendinopathies include steroid injections and operative treatment. However, these present a list of potential complications and hence, interest in alternative interventions, such as platelet-rich plasma (PRP), is growing. We review the recent high-level evidence discussing the use of PRP and its efficacy on three upper limb tendinopathies; lateral epicondylitis, rotator cuff tears, and impingement syndrome.

Study Design and Methods

A literature search was performed using PubMed and the Cochrane Library. Level 1 and level 2 literature was included. Main outcomes included function, pain, and biological healing.


Fifteen studies were included (13 randomized control trials (RCTs) and 2 systematic reviews).


Three RCTs reported increased benefit of PRP compared to corticosteroid (CS) injections and laser therapy. Other studies reported that PRP, CS, local anesthetic, and autologous whole blood are all beneficial. Benefits of PRP significantly increased in the long term.

Rotator Cuff Tears

A mixture of results, potentially related to different methods of PRP administration.

Impingement Syndrome

One study reports significant benefit when PRP used during decompression surgery.


The variability of factors suggests that there is a need for standards of PRP to be set. However, even with such variability, PRP may be used as a safe and effective treatment for epicondylitis. The benefit of PRP use in rotator cuff repair augmentation is mixed and further evidence is needed to reach any conclusion for the use of PRP in subacromial decompression. Additional research is needed to determine optimum dosage and administration methods.

Lay Summary

This article discusses new treatments for diseases involving the shoulder and elbow including tennis elbow, rotator cuff tendon tears, and impingement syndrome. This method of treatment is known as platelet-rich plasma (PRP). PRP is a substance which is gathered from the patients’ own blood and introduced to sites of tendon injuries via injection or as a gel. This substance includes factors that speed healing and recovery of these injured tendons. This in turn allows for reduction in pain and improvement in function of joints. Our review shows promising results for the use of PRP in treating these conditions.

Future Works

Future works surrounding the use of platelet-rich plasma (PRP) will need to determine a gold standard for preparation of PRP. They will also attempt to establish the best practice for dosing and administering the substance. Future studies will aim to provide guidelines for bringing PRP into clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others


  1. Shiri R, Viikari-Juntura E, Varonen H, Heliovaara M. Prevalence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol. 2006;164(11):1065–74.

    Article  Google Scholar 

  2. Minagawa H, Yamamoto N, Abe H, Fukuda M, Seki N, Kikuchi K, et al. Prevalence of symptomatic and asymptomatic rotator cuff tears in the general population: from mass-screening in one village. J Orthop. 2013;10(1):8–12.

    Article  Google Scholar 

  3. Urwin M, Symmons D, Allison T, Brammah T, Busby H, Roxby M, et al. Estimating the burden of musculoskeletal disorders in the community: the comparative prevalence of symptoms at different anatomical sites, and the relation to social deprivation. Ann Rheum Dis. 1998;57(11):649–55.

    Article  Google Scholar 

  4. Andres BM, Murrell GAC. Treatment of tendinopathy: what works, what does not, and what is on the horizon. Clin Orthop Relat Res. 2008;466(7):1539–54.

    Article  Google Scholar 

  5. Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet. 2010;376(9754):1751–67.

    Article  Google Scholar 

  6. Kampa RJ, Connell DA. Treatment of tendinopathy: is there a role for autologous whole blood and platelet rich plasma injection?: treatment of chronic tendinopathy. Int J Clin Pract. 2010;64(13):1813–23.

    Article  Google Scholar 

  7. Autologous blood injection for tendinopathy | 1-Guidance | Guidance and guidelines | NICE [Internet]. Available from: Accessed August 2016.

  8. Arnoczky SP, Delos D, Rodeo SA. What is platelet-rich plasma? Oper Tech Sports Med. 2011;19(3):142–8.

    Article  Google Scholar 

  9. Mei-Dan O, Carmont MR. Autologous blood products in rotator cuff repair. Med Sport Sci. 2011;57:65–75. Available from: Accessed 16 Aug 2016

    Article  Google Scholar 

  10. Clark RAF. The molecular and cellular biology of wound repair. 2nd ed. New York: Plenum Press; 1996.

    Google Scholar 

  11. Gautam VK, Verma S, Batra S, Bhatnagar N, Arora S. Platelet-rich plasma versus corticosteroid injection for recalcitrant lateral epicondylitis: clinical and ultrasonographic evaluation. J OrthopSurg (Hong Kong). 2015;23(1):1–5.

    Article  Google Scholar 

  12. Omar AS, Ibrahim ME, Ahmed AS, Said M. Local injection of autologous platelet rich plasma and corticosteroid in treatment of lateral epicondylitis and plantar fasciitis: randomized clinical trial. Egypt Rheumatol. 2012;34(2):43–9.

    Article  Google Scholar 

  13. Yadav R. Comparison of local injection of platelet rich plasma and corticosteroids in the treatment of lateral epicondylitis of humerus. J Clin Diagn Res 2015 Available from: Accessed August 2016.

  14. Raeissadat SA, Rayegani SM, Hassanabadi H, et al. Is platelet-rich plasma superior to whole blood in the management of chronic tennis elbow: one year randomized clinical trial. BMC Sports Sci Med Rehabil. 2014;6(1):12. Available from: Accessed August 2016

    Article  Google Scholar 

  15. Palacio EP, Schiavetti RR, Kanematsu M, Ikeda TM, Mizobuchi RR, Galbiatti JA. Effects of platelet-rich plasma on lateral epicondylitis of the elbow: prospective randomized controlled trial. Rev Bras Ortop. 2016;51(1):90–5.

    Article  Google Scholar 

  16. Tonk G, Kumar A, Gupta A. Platelet rich plasma versus laser therapy in lateral epicondylitis of elbow. Indian J Orthop. 2014;48(4):390–3.

    Article  Google Scholar 

  17. Murray DJ, Javed S, Jain N, Kemp S, Watts AC. Platelet—rich—plasma injections in treating lateral epicondylosis: a review of the recent evidence. J Hand Microsurg. 2015;7(2):320–5.

    Article  Google Scholar 

  18. Creaney L, Wallace A, Curtis M, Connell D. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet- rich plasma injections. Br J Sports Med. 2011;45(12):966–71.

    Article  Google Scholar 

  19. Thanasas C, Papadimitriou G, Charalambidis C, Paraskevopoulos I, Papanikolaou A. Platelet-rich plasma versus autologous whole blood for the treat- ment of chronic lateral elbow epicondylitis—a randomized con- trolled clinical trial. Am J Sports Med. 2011;39(10):2130–4.

    Article  Google Scholar 

  20. Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial. Am J Sports Med. 2010;38(2):255–32.

    Article  Google Scholar 

  21. Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med. 2011;39(6):1200–8.

    Article  Google Scholar 

  22. Krogh TP, Fredberg U, Stengard-Pederson K, et al. Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial. Am J Sports Med. 2013;41(3):625–34.

    Article  Google Scholar 

  23. Mishra A, Harmon K, Woodall J Jr, Vieira A. Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol. 2012;13(7):1185–95.

    Article  Google Scholar 

  24. Wang A, McCann P, Colliver J, Koh E, Ackland T, Joss B, et al. Do postoperative platelet-rich plasma injections accelerate early tendon healing and functional recovery after arthroscopic supraspinatus repair?: a randomized controlled trial. Am J Sports Med. 2015;43(6):1430–7.

    Article  Google Scholar 

  25. Sugaya H, Maeda K, Matsuki K, Moriishi J. Functional and structural outcome after arthroscopic full-thickness rotator cuff repair: single-row versus dual-row fixation. Arthroscopy. 2005;21(11):1307–16.

    Article  Google Scholar 

  26. Gumina S, Campagna V, Ferrazza G, Giannicola G, Fratalocchi F, Milani A, et al. Use of platelet-leukocyte membrane in arthroscopic repair of large rotator cuff tears: a prospective randomized study. J Bone Joint Surg Am. 2012;94(15):1345–52.

    Article  Google Scholar 

  27. Zumstein MA, Rumian A, Thélu CÉ, Lesbats V, O'Shea K, Schaer M, et al. SECEC research grant 2008 II: use of platelet- and leucocyte-rich fibrin (L-PRF) does not affect late rotator cuff tendon healing: a prospective randomized controlled study. J Shoulder Elb Surg. 2016;25(1):2–11.

    Article  Google Scholar 

  28. Flury M, Rickenbacher D, Schwyzer H-K, Jung C, Schneider MM, Stahnke K, et al. Does pure platelet-rich plasma affect postoperative clinical outcomes after arthroscopic rotator cuff repair? A randomized controlled trial. Am J Sports Med. 2016;44(8):2136–46.

    Article  Google Scholar 

  29. Cohn CS, Lockhart E, McCullough JJ. The use of autologous platelet-rich plasma in the orthopedic setting. Transfusion. 2015;55(7):1812–20.

    Article  Google Scholar 

  30. Randelli P, Arrigoni P, Ragone V, Aliprandi A, Cabitza P. Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2-year follow-up. J Shoulder Elb Surg. 2011;20(4):518–28.

    Article  Google Scholar 

  31. Jo CH, Kim JE, Yoon KS, Lee JH, Kang SB, Lee JH, et al. Does platelet-rich plasma accelerate recovery after rotator cuff repair? A prospective cohort study. Am J Sports Med. 2011;39(10):2082–90.

    Article  Google Scholar 

  32. Weber SC, Kauffman JI, Parise C, Weber SJ, Katz SD. Platelet-rich fibrin matrix in the management of arthroscopic repair of the rotator cuff: a prospective, randomized, double-blinded study. Am J Sports Med. 2013;41(2):263–70.

    Article  Google Scholar 

  33. Castricini R, Longo UG, De Benedetto M, Panfoli N, Pirani P, Zini R, et al. Platelet-rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. Am J Sports Med. 2011;39(2):258–65.

    Article  Google Scholar 

  34. Rodeo SA, Delos D, Williams RJ, Adler RS, Pearle A, Warren RF. The effect of platelet-rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. Am J Sports Med. 2012;40(6):1234–41.

    Article  Google Scholar 

  35. Pandey V, Bandi A, Madi S, Agarwal L, Acharya KKV, Maddukuri S, et al. Does application of moderately concentrated platelet-rich plasma improve clinical and structural outcome after arthroscopic repair of medium-sized to large rotator cuff tear? A randomized controlled trial. J Shoulder Elb Surg. 2016;25(8):1312–22.

    Article  Google Scholar 

  36. Zhang Z, Wang Y, Sun J. The effect of platelet-rich plasma on arthroscopic double-row rotator cuff repair: a clinical study with 12-month follow-up. Acta Orthop Traumatol Turc. 2016;50(2):191–7.

    Google Scholar 

  37. Everts PA, Devilee RJJ, Brown Mahoney C, et al. Exogenous application of platelet-leukocyte gel during open subacromial decompression contributes to improved patient outcome. Eur Surg Res. 2007;40(2):203–10.

    Article  Google Scholar 

  38. Nirschl RP, Pettrone FA. Tennis elbow. The surgical treatment of lateral epicondylitis. J Bone Joint Surg Am. 1979;61(6):832–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Karan Chawla.

Ethics declarations

Conflict of Interest

The authors declare they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chawla, K., Mittal, S. & Kumar, K. A Systematic Review of Platelet-Rich Plasma in the Management of Upper Limb Tendinopathies. Regen. Eng. Transl. Med. 3, 224–232 (2017).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: